GSK gets FDA nod for Jemperli indicated for endometrial cancer... Apr 26
The FDA is granted accelerated approval to Jemperli (dostarlimab)) for treatment of patients with recurrent and advanced endometrial cancer that has progressed with the prior ... Apr 24
... Dec 16
-Advertisements-